Notice NOT-MD-19-014 from the NIH Guide for Grants and Contracts

Notice NOT-MD-19-011 from the NIH Guide for Grants and Contracts

Notice NOT-MD-19-010 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AT-19-009 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Center for Complementary and Integrative Health (NCCIH) solicits grant research applications to study minor cannabinoids and terpenes in the cannabis plant as it relates to pain and nociception. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids and terpenes of particular interest include the following: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ?-caryophyllene, Limonene, ?-terpineol, Linalool, ?-phellandrene, ?-pinene, ?-pinene, ?-terpinene, and ?-humulene. This initiative intends to support highly innovative basic and/or mechanistic studies in appropriate model organisms and/or human subjects aiming to identify, describe and determine whether minor cannabinoids and/or terpenes can help treat pain. The mechanisms and processes underlying potential contribution of minor cannabinoids and terpenes to pain relief and functional restoration in patients with different pain conditions may be very broad. This initiative encourages interdisciplinary collaborations by experts from multiple fieldspharmacologists, chemists, physicists, physiologists, neuroscientists, psychologists, endocrinologists, immunologists, geneticists, behavioral scientists, clinicians, and others in relevant fields of inquiry.

Funding Opportunity RFA-AT-19-008 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Center for Complementary and Integrative Health (NCCIH) solicits grant research applications to study minor cannabinoids and terpenes in the cannabis plant as it relates to pain and nociception. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids and terpenes of particular interest include the following: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ?-caryophyllene, Limonene, ?-terpineol, Linalool, ?-phellandrene, ?-pinene, ?-pinene, ?-terpinene, and ?-humulene. This initiative intends to support highly innovative basic and/or mechanistic studies in appropriate model organisms and/or human subjects aiming to identify, describe and determine whether minor cannabinoids and/or terpenes can help treat pain. The mechanisms and processes underlying potential contribution of minor cannabinoids and terpenes to pain relief and functional restoration in patients with different pain conditions may be very broad. This initiative encourages interdisciplinary collaborations by experts from multiple fieldspharmacologists, chemists, physicists, physiologists, neuroscientists, psychologists, endocrinologists, immunologists, geneticists, behavioral scientists, clinicians, and others in relevant fields of inquiry.

Notice NOT-CA-19-016 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-051 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Clinical Bioinformatician Bioinformatics, Permanent, Rare Diseases and Cancer! Paramount are working in partnership with Genomics England who have successfully completed their 100,000 Genomes Project and are now working with the NHS to create the w London, England

Negotiable: Paramount Recruitment: Bioinformatics Operations Manager Bioinformatics, Permanent, Central London! Paramount are working in partnership with Genomics England to help expand their team - after successfully completing the 100,000 Genomes Project recently they are working London, England

PhD Degree in a quantitative discipline (e.g., statistics, operations research, bioinformatics, economics, computational biology, computer science, mathematics,...
From Schneider National - Thu, 03 Jan 2019 06:22:26 GMT - View all Green Bay, WI jobs

Work with Cytometry/Cytof teams, Bioinformatics Analysis, Modeling, and Theory team, Immunology, Infrastructure teams, and external partners to facilitate data...
From Allen Institute for Immunology - Thu, 03 Jan 2019 02:27:35 GMT - View all Seattle, WA jobs

Doctoral degree (PhD or equivalent) in Computer Science, Biomedical Informatics, Bioinformatics, Computational Biology, Statistics, or a closely related...
From University of Wisconsin–Madison - Thu, 03 Jan 2019 00:57:15 GMT - View all Madison, WI jobs

PhD Degree in a quantitative discipline (e.g., statistics, operations research, bioinformatics, economics, computational biology, computer science, mathematics,...
From Schneider - Wed, 02 Jan 2019 23:36:22 GMT - View all Green Bay, WI jobs

A Blue Gene/L and 3 racks of Linux GPU supercomputers for computational biology and bioinformatics; The Institute’s research success has resulted in a second...
From University of Minnesota - Wed, 02 Jan 2019 19:59:32 GMT - View all Job, WV jobs

A Blue Gene/L and 3 racks of Linux GPU supercomputers for computational biology and bioinformatics; The Institute’s research success has resulted in a second...
From University of Minnesota - Wed, 02 Jan 2019 19:59:31 GMT - View all Job, WV jobs

Familiarity with bioinformatics tools. Familiarity with the analysis of next generation sequencing data. A good understanding of protein biochemistry, next...
From Just Biotherapeutics - Wed, 02 Jan 2019 19:29:22 GMT - View all Seattle, WA jobs

Notice NOT-AG-18-057 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-19-009 from the NIH Guide for Grants and Contracts. The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of cancer, environmental health, heart disease, blood disorders, diseases of the eye and visual system, mental health, and neurological disorders. Partnering U.S. and Chinese investigators must work jointly to submit identical applications to NIH and National Natural Science Foundation of China (NSFC), respectively. U.S. investigators must respond to the announcement from NIH, including the Chinese application as an attachment, and Chinese investigators must respond to a separate funding announcement from NSFC, including the NIH application as an attachment.

Notice NOT-AG-18-056 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-050 from the NIH Guide for Grants and Contracts